Abstract

Oleg P Zhirnov1*, Tatyana Y Matrosovich2, Mikhail N Matrosovich2, Hans-Dieter Klenk2
1 DI Ivanovsky Institute of Virology, Moscow, Russia
2 Institute of Virology, Marburg, Germany
* Corresponding author e-mail:
To ensure complete transparency, the authors of this article published in Antiviral Chemistry & Chemotherapy Volume 21 Issue 4 [1] would like to report the following competing interest.
Footnotes
OPZ has US, European, and Russian patents concerning the use of aerosolized aprotinin against influenza. All other authors declare no competing interests.
